Holen Sie sich die Stockscreener-App
1.43
2.72%
-0.04
Handel nachbörslich:
1.44
0.01
+0.70%
Schlusskurs vom Vortag:
$1.47
Offen:
$1.47
24-Stunden-Volumen:
454.55K
Relative Volume:
0.52
Marktkapitalisierung:
$152.54M
Einnahmen:
$45.44M
Nettoeinkommen (Verlust:
$-35.43M
KGV:
-4.2059
EPS:
-0.34
Netto-Cashflow:
$-25.39M
1W Leistung:
-7.74%
1M Leistung:
-7.14%
6M Leistung:
-36.44%
1J Leistung:
-68.71%
1-Tages-Spanne:
$1.43
$1.49
1-Wochen-Bereich:
$1.43
$1.59
52-Wochen-Spanne:
$1.26
$5.20
Maxcyte Inc Stock (MXCT) Company Profile
Firmenname
Maxcyte Inc
Sektor
Branche
Telefon
301-517-5556
Adresse
9713 KEY WEST AVENUE,, ROCKVILLE
Vergleichen Sie MXCT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MXCT
Maxcyte Inc
|
1.43 | 156.81M | 45.44M | -35.43M | -25.39M | -0.34 |
|
ABT
Abbott Laboratories
|
125.92 | 219.41B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
97.64 | 145.84B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
367.54 | 140.43B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
97.53 | 126.52B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.13 | 49.08B | 5.88B | 1.34B | 799.60M | 2.3489 |
Maxcyte Inc Stock (MXCT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-11 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-08-07 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2025-07-22 | Eingeleitet | Stephens | Overweight |
| 2023-11-29 | Eingeleitet | Craig Hallum | Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-08-24 | Eingeleitet | BTIG Research | Buy |
| 2021-08-24 | Eingeleitet | Cowen | Outperform |
| 2021-08-24 | Eingeleitet | Stephens | Overweight |
| 2021-08-24 | Eingeleitet | Stifel | Buy |
| 2021-08-24 | Eingeleitet | Wedbush | Outperform |
| 2021-08-24 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Maxcyte Inc Aktie (MXCT) Neueste Nachrichten
Risk Off: Can TriNet Group Inc. stock maintain growth trajectory2025 Technical Patterns & Fast Entry Momentum Trade Alerts - moha.gov.vn
Will MaxCyte Inc. stock rally after Fed decisionsStop Loss & Weekly Market Pulse Alerts - ulpravda.ru
MaxCyte® acquires SeQure Dx to broaden cell engineering offerings with on-target and off-target editing assessments - MSN
MaxCyte: Building the Future of Cell and Gene Therapy Innovation - MSN
MaxCyte (NASDAQ:MXCT) Stock Rating Lowered by Wall Street Zen - Defense World
How strong is MaxCyte Inc. stock balance sheet2025 Performance Recap & Community Driven Trade Alerts - ulpravda.ru
Is MaxCyte Inc. stock attractive after correctionTrail vs Road Selection & walk-ready comfort choices - ulpravda.ru
Will MaxCyte Inc. stock gain from government policiesTrade Volume Report & Entry and Exit Point Strategies - ulpravda.ru
Why MaxCyte Inc. stock remains undervaluedJuly 2025 Trends & Verified Short-Term Trading Plans - ulpravda.ru
Aug Outlook: Will MaxCyte Inc. stock gain from government policiesWeekly Trade Report & Risk Managed Investment Entry Signals - ulpravda.ru
How sustainable is MaxCyte Inc. stock dividend payout2025 Technical Patterns & Weekly Breakout Stock Alerts - ulpravda.ru
Will MaxCyte Inc. stock outperform value stocksWeekly Gains Report & Free Community Supported Trade Ideas - ulpravda.ru
Downgrade Watch: Why retail investors pile into MaxCyte Inc. stockQuarterly Profit Report & Accurate Buy Signal Notifications - ulpravda.ru
MaxCyte (NASDAQ:MXCT) Shares Up 0.7% – Time to Buy? - Defense World
Bear Alert: How strong is MaxCyte Inc stock balance sheet2025 Market Sentiment & Real-Time Volume Analysis - moha.gov.vn
Aug Patterns: Will MaxCyte Inc stock gain from government policiesInflation Watch & Safe Capital Growth Stock Tips - moha.gov.vn
MaxCyte, Inc.Common Stock (NQ: MXCT - FinancialContent
Will MaxCyte Inc. stock attract more institutional investorsBlue Chip Stock Analysis & Free Trading Psychology Coaching - ulpravda.ru
Will MaxCyte Inc. stock deliver strong dividend growth2026 world cup usa national team group stage defensive leaders pressing system tactical prediction guide - ulpravda.ru
MaxCyte eyes growth in cell engineering for 2026 - Traders Union
MXCT’s price-to-cash ratio: How it affects the stock’s valuation. - uspostnews.com
MaxCyte advances GMP process with KSQ partnership - Traders Union
Activity Recap: Why GIGGU stock appeals to dividend seekersTrade Entry Report & Smart Allocation Stock Reports - moha.gov.vn
Will MaxCyte Inc. stock benefit from sector rotationShare Buyback & Capital Efficient Trade Techniques - Улправда
Why retail investors pile into MaxCyte Inc. stock2025 Price Targets & Fast Entry Momentum Trade Alerts - Улправда
Is MaxCyte Inc. stock a bargain at current levels2025 Major Catalysts & Free Long-Term Investment Growth Plans - Улправда
Stock Recap: How buybacks impact MaxCyte Inc. stock valueJuly 2025 Summary & Verified Technical Trade Signals - DonanımHaber
MaxCyte, Inc.(NasdaqGS: MXCT) dropped from NASDAQ Biotechnology Index - MarketScreener
MaxCyte, Inc. (NASDAQ:MXCT) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
William Blair Downgrades MaxCyte (MXCT) - MSN
Prepare Yourself for Liftoff: MaxCyte Inc (MXCT) - setenews.com
Healthy Upside Potential: MaxCyte Inc (MXCT) - setenews.com
Mirabella Financial Services LLP Has $14.39 Million Stock Position in MaxCyte, Inc. $MXCT - MarketBeat
How MaxCyte Inc. (MYE0) stock compares with market leadersWeekly Stock Report & Smart Swing Trading Techniques - Newser
Is MaxCyte Inc. (MYE0) stock attractive post correction2025 Top Gainers & Daily Price Action Insights - Newser
Can MaxCyte Inc. (MYE0) stock stage a strong rebound this quarterJuly 2025 Sector Moves & Short-Term Swing Trade Alerts - Newser
Is MaxCyte Inc. stock attractive for ETFsTrade Risk Summary & Consistent Return Strategy Ideas - Newser
Why analysts recommend MaxCyte Inc. (MYE0) stockJuly 2025 Trends & Weekly Setup with ROI Potential - Newser
Is MaxCyte Inc. (MYE0) stock dividend growth reliableAnalyst Upgrade & Stepwise Trade Execution Plans - Newser
MaxCyte drives CAR T manufacturing optimization using ExPERT system - Traders Union
Dividend Watch: Why Clearway Energy Inc. (NY4B) stock is upgraded to buyJuly 2025 Volume & Verified Technical Signals - BỘ NỘI VỤ
MaxCyte (MXCT) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Cellares Appoints Former MaxCyte Commercial Chief Ali Soleymannezhad as Chief Commercial Officer to Lead Global IDMO Expansion, Catalyze Next Wave of Partnerships, Prepare for IPO - Morningstar
The time has not yet come to remove your chips from the table: MaxCyte Inc (MXCT) - setenews.com
MaxCyte aims to optimize CAR T manufacturing with ExPERT system - Traders Union
MaxCyte (NASDAQ:MXCT) Stock Rating Upgraded by Wall Street Zen - Defense World
MaxCyte, Inc. (NASDAQ:MXCT) Receives Average Rating of "Hold" from Analysts - MarketBeat
MXCT SEC FilingsMaxcyte 10-K, 10-Q, 8-K Forms - Stock Titan
What drives MaxCyte Inc MYE0 stock priceRSI Overbought/Oversold & Daily Tips From Top Market Analysts - earlytimes.in
How MaxCyte Inc. (MYE0) stock reacts to fiscal policiesJuly 2025 Market Mood & Safe Entry Point Alerts - newser.com
Can MaxCyte Inc. (MYE0) stock reach $200 price target2025 Major Catalysts & Weekly High Return Opportunities - newser.com
Finanzdaten der Maxcyte Inc-Aktie (MXCT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.31%
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):